Pain-free survival after vagoglossopharyngeal complex sectioning with or without microvascular decompression in glossopharyngeal neuralgia

Abstract

OBJECTIVEGlossopharyngeal neuralgia (GN) is a rare pain condition in which patients experience paroxysmal, lancinating throat pain. Multiple surgical approaches have been used to treat this condition, including microvascular decompression (MVD), and sectioning of cranial nerve (CN) IX and the upper rootlets of CN X, or a combination of the two. The aim of this study was to examine the long-term quality of life and pain-free survival after MVD and sectioning of the CN X/IX complex.METHODSA combined retrospective chart review and a quality-of-life telephone survey were performed to collect demographic and long-term outcome data. Quality of life was assessed by means of a questionnaire based on a combination of the Barrow Neurological Institute pain intensity scoring criteria and the Brief Pain Inventory–Facial. Kaplan-Meier analysis was performed to determine pain-free survival.RESULTSOf 18 patients with GN, 17 underwent sectioning of the CN IX/X complex alone or sectioning and MVD depending on the presence of a compressing vessel. Eleven of 17 patients had compression of CN IX/X by the posterior inferior cerebellar artery, 1 had compression by a vertebral artery, and 5 had no compression. One patient (6%) experienced no immediate pain relief. Fifteen (88%) of 17 patients were pain free at the last follow-up (mean 9.33 years, range 5.16–13 years). One patient (6%) experienced throat pain relapse at 3 months. The median pain-free survival was 7.5 years ± 10.6 months. Nine of 18 patients were contacted by telephone. Of the 17 patients who underwent sectioning of the CN IX/X complex, 13 (77%) patients had short-term complaints: dysphagia (n = 4), hoarseness (n = 4), ipsilateral hearing loss (n = 4), ipsilateral taste loss (n = 2), and dizziness (n = 2) at 2 weeks. Nine patients had persistent side effects at latest follow-up. Eight of 9 telephone respondents reported that they would have the surgery over again.CONCLUSIONSSectioning of the CN IX/X complex with or without MVD of the glossopharyngeal nerve is a safe and effective surgical therapy for GN with initial pain freedom in 94% of patients and an excellent long-term pain relief (mean 7.5 years).

Contemporary concepts of pain surgery

“…88 Of note, some rarer conditions such as glossopharyngeal neuralgia and intermedius (geniculate) neuralgia may also respond well to destructive procedures. 42,109 The Future of Pain Surgery…”

Percutaneous Pulsed Radiofrequency Treatment in a Patient with Chronic Bilateral Painful Glossopharyngeal Neuropathy

“…When comparing nerve sectioning, microvascular decompression, or stereotactic radiosurgery, nerve section provided the most favorable treatment response [21]. Sectioning of the cranial nerves IX and X, microvascular decompression or a combination of the 2 has been suggested as a safe and effective surgical therapy [22].…”

CT-Guided Percutaneous Trigeminal Tractotomy-Nucleotomy for Intractable Craniofacial Pain

“…Particularly, craniofacial cancer-related intractable pain can be best managed via destructive procedures such as trigeminal TR-NC in patients with low life expectancies. Trigeminal TR-NC has been advocated as the first-line treatment in patients with glossopharyngeal and geniculate neuralgias, even prior to microvascular decompression (MVD) [1], given the potential mortality and morbidity risks associated with MVD [17, 18]. In addition, patients with trigeminal neuralgia who experience failed MVD therapy and those with bilateral facial pain or atypical facial pain have been underlined as potential candidates for TR-NC procedures [1, 7, 9].…”